Summary
Zoetis Inc. (ZTS) has filed an 8-K report on February 19, 2016, detailing key changes to its corporate governance and dividend policy. The most significant update is the adoption of new "proxy access" provisions within the company's By-laws. These amendments will enable eligible shareholders, who collectively own at least 3% of the company's stock for a minimum of three years, to nominate director candidates to be included in the company's proxy materials for annual meetings following the 2016 meeting. This move represents an effort by Zoetis to enhance shareholder rights and participation in board elections, a development investors should monitor for its potential impact on board composition and corporate strategy.
Key Highlights
- 1Zoetis Inc. adopted new "proxy access" provisions in its By-laws, effective after the 2016 Annual Meeting.
- 2Eligible shareholders holding at least 3% of common stock for three continuous years can nominate directors.
- 3Shareholders can nominate up to the greater of two directors or 20% of the Board.
- 4The By-laws were updated to clarify voting in contested elections involving proxy access nominees.
- 5Residual references to former parent company "Pfizer Inc." have been removed from the By-laws.
- 6The company declared a quarterly dividend of $0.095 per share for the second quarter of 2016.
- 7The dividend payment date is June 1, 2016, with a record date of April 7, 2016.